[DVAX] Dynavax Technologies

Symbol: DVAX Last Price: 1.47 Change: 0.00 (0.00%) Website: click here

- Under the agreement Novartis will provide Dynavax a supply of trivalent influenza vaccine, an essential component of Dynavax's Universal Influenza Vaccine, for both clinical trial use and vaccine sales. Novartis receives an exclusive option to negotiate a Joint Development and Commercialization Agreement with Dynavax.
- Under the agreement Dynavax will conduct early-stage development through a defined proof-of-concept. If Novartis exercises the right to negotiate a further agreement for development and commercialization, Dynavax would retain co-commercialization rights in the U.S. and receive product royalties outside of the U.S. Should the option not be exercised, Novartis remains committed to providing commercial supply of trivalent influenza vaccine with pre-agreed commercial terms and Dynavax retains the right to independently continue with late-stage development and commercialization.

Other headlines for [DVAX]

• DVAX 8/28/2008 04:22pm
  Dynavax Technologies Ends loan pact with Deerfield - filing dated 8/26- On August 26, 2008, Dynavax Technologies Corporation (“Dynavax”) and Deerfield Private Design Fund, L.P., Deerfield Special Situations Fund, L.P., more...
  
• DVAX 8/5/2008 04:09pm
  Dynavax Technologies Reports Q2 -$0.15 v -$0.28e, R$10M v $8.3Me- As of June 30, 2008, Dynavax reported cash, cash equivalents, marketable securities and investments held by Symphony Dynamo, Inc. (SDI) totaling $63.1 more...
  
• DVAX 8/5/2008 04:06pm
  Dynavax Technologies Phase III trial with MRK for hepatitis B vaccine met primary endpoint- The study achieved its primary endpoint. HEPLISAV is being jointly developed by Dynavax and Merck for use in adults and in more...
  
• DVAX 7/23/2008 04:12pm
  Dynavax Technologies Enters into supply and option agreement for development of Universal Influenza Vaccine with Novartis- Under the agreement Novartis will provide Dynavax a supply of trivalent influenza vaccine, an more...
  

Healthcare sector headlines

• GENZ Today 06:09am
  Genzyme Corp Morgan Stanley Initiates GENZ with Overweight
  
• UTMD Today 06:05am
  Utah Medical Products Inc. Files $100M Mixed Securities Shelf
  
• AMED Today 06:00am
  Amedisys Inc Signs purchase agreement to acquire six home health agencies in three states- co. announced it has signed a purchase agreement to acquire six home health locations from Home Health Corporation of more...
  
• NUVA Today 05:49am
  NuVasive Inc Piper Jaffray Initiates NUVA with Buy
  
• QLTI Today 05:42am
  QLT Inc Morgan Stanley Cuts QLTI to Underweight from Equal Weight